Nicotinamide treatment in subjects at high risk of developing IDDM improves insulin secretion

British Journal of Clinical Practice

Volumn 46, Issue 3, 1992, Pages 177-179

  Manna, R ^a   Migliore, A ^a   Martin, L S ^a   Ferrara, E ^a   Ponte, E ^a   Marietti, G ^a   Scuderi, F ^a   Cristiano, G ^a   Ghirlanda, G ^a   Gambassi, G ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; NICOTINAMIDE; PANCREAS ISLET CELL ANTIBODY;

ADOLESCENT; ADULT; ANTIBODY TITER; ARTICLE; AUTOIMMUNITY; CELL FUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; HIGH RISK PATIENT; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; INTRAVENOUS GLUCOSE TOLERANCE TEST; ORAL DRUG ADMINISTRATION; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROPHYLAXIS; SCHOOL CHILD; SCREENING;

ADOLESCENT; ADULT; CHILD; DIABETES MELLITUS, INSULIN-DEPENDENT; HUMAN; INSULIN; ISLETS OF LANGERHANS; NIACINAMIDE; PILOT PROJECTS; RISK FACTORS;

EID: 0026805956     PISSN: 00070947     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)